NCT03040089View on ClinicalTrials.gov

Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 595 nm

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 9, 2016

Primary Completion Date

July 15, 2016

Study Completion Date

September 26, 2016

Conditions
Melasma
Interventions
DEVICE

PICO+4

picosecond, neodymium-doped yttrium aluminum garnet laser

DRUG

Neoquine Cream 2%

2% hydroquinone cream

Sponsors
All Listed Sponsors
lead

LUTRONIC Corporation

INDUSTRY